V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16686555 | 330034907 | EEI00 | 55 | X729 | 1 | 2014-09-18 | ETOPOSIDE | 330001484 | 330000292 | 330000594 |
| 16686556 | 330034907 | EE105 | 8 | X721 | 1 | 2014-10-15 | CAPECITABINE | 330001484 | 330000292 | 330000594 |
| 16686557 | 330034907 | EE813 | 8 | null | 1 | 2014-10-16 | CYCLOPHOSPHAMIDE | 330001484 | 330000292 | 330000594 |
| 16686558 | 330034907 | EE101 | 3950 | null | 1 | 2015-01-31 | BORTEZOMIB | 330001484 | 330000292 | 330000594 |
| 16686559 | 330034907 | ECL01 | 9.2 | null | 1 | 2015-02-07 | VINORELBINE | 330001484 | 330000292 | 330000594 |
| 16686560 | 330034907 | ECL01 | 2250 | X723 | 1 | 2015-02-07 | MITOMYCIN | 330001484 | 330000292 | 330000594 |
| 16686561 | 330034907 | EUDJC | 20 | X721 | 1 | 2015-02-07 | CYTARABINE | 330001484 | 330000292 | 330000594 |
| 16686562 | 330034907 | EUDUU | 8 | X724 | 2 | 2015-02-08 | METHOTREXATE | 330001484 | 330000292 | 330000594 |
| 16686563 | 330034907 | E1UZ0 | 32 | X721 | 1 | 2015-02-08 | GEMCITABINE | 330001484 | 330000292 | 330000594 |
| 16686564 | 330034907 | EDZ01 | 32 | X724 | 2 | 2015-02-08 | PACLITAXEL | 330001484 | 330000292 | 330000594 |
| 16686565 | 330034908 | EZ1 | 8 | X721 | 1 | 2018-06-03 | LIPOSOMAL DOXORUBICIN | 330001663 | 330000331 | 330000654 |
| 16686566 | 330034908 | ED301 | 25 | null | 2 | 2018-06-03 | NELARABINE | 330001663 | 330000331 | 330000654 |
| 16686567 | 330034908 | EE813 | 4 | null | 1 | 2018-06-03 | GEMCITABINE | 330001663 | 330000331 | 330000654 |
| 16686568 | 330034909 | EEI00 | 200 | null | 2 | null | VINCRISTINE | 330001855 | 330000370 | 330000730 |
| 16686569 | 330034909 | EUDJC | 600 | null | 5 | null | NELARABINE | 330001855 | 330000370 | 330000730 |
| 16686570 | 330034910 | EOI | 2.38 | X723 | 1 | 2013-11-13 | CETUXIMAB | 330001888 | 330000375 | 330000740 |
| 16686571 | 330034910 | EE813 | 140 | null | 1 | 2014-02-05 | BEVACIZUMAB | 330001888 | 330000375 | 330000740 |
| 16686572 | 330034912 | EUJ01 | 164 | X723 | 1 | 2013-10-02 | DABRAFENIB | 330002151 | 330000445 | 330000847 |
| 16686573 | 330034912 | EGQ01 | 6.25 | X723 | 1 | 2013-10-02 | MITOXANTRONE | 330002151 | 330000445 | 330000847 |
| 16686574 | 330034915 | ECL01 | 98 | X724 | 2 | null | PACLITAXEL | 330002339 | 330000506 | 330000938 |
| 16686575 | 330034915 | ERA20 | null | X724 | 1 | null | METHOTREXATE | 330002339 | 330000506 | 330000938 |
| 16686576 | 330034915 | EK1PP | 164 | null | 1 | null | DABRAFENIB | 330002339 | 330000506 | 330000938 |
| 16686577 | 330034915 | ED301 | 660 | null | 2 | null | BORTEZOMIB | 330002339 | 330000506 | 330000938 |
| 16686578 | 330034915 | EC4 | 60 | null | 1 | null | ZOLEDRONIC ACID | 330002339 | 330000506 | 330000938 |
| 16686579 | 330034915 | ELW | 30 | null | 2 | null | NOT CHEMO | 330002339 | 330000506 | 330000938 |
| 16686580 | 330034915 | EKU01 | 0 | X724 | 1 | null | PEMBROLIZUMAB | 330002339 | 330000506 | 330000938 |
| 16686581 | 330034916 | ECL01 | 450 | X724 | 1 | null | CETUXIMAB | 330002766 | 330000603 | 330001099 |
| 16686582 | 330034917 | EW100 | 3200 | null | 1 | null | PACLITAXEL | 330002845 | 330000619 | 330001131 |
| 16686583 | 330034918 | ECL02 | 960 | null | 2 | null | CYTARABINE | 330003143 | 330000691 | 330001240 |
| 16686584 | 330034919 | EW100 | 4375 | X724 | 1 | null | CISPLATIN | 330003258 | 330006439 | 330001286 |
| 16686585 | 330034920 | EJS03 | 60 | null | 1 | 2018-01-16 | VINCRISTINE | 330003362 | 330000754 | 330001334 |
| 16686588 | 330034926 | EGQ01 | 1 | X729 | 2 | 2016-12-05 | MITOXANTRONE | 330008133 | 330001213 | 330002163 |
| 16686589 | 330034927 | EGENG | 36 | null | 2 | null | CYTARABINE | 330008190 | 330001229 | 330002187 |
| 16686590 | 330034928 | ED617 | 4 | X729 | 2 | 2017-08-04 | CYCLOPHOSPHAMIDE | 330008235 | 330001241 | 330002203 |
| 16686591 | 330034929 | ERA20 | 1 | X724 | 2 | 2016-01-24 | NELARABINE | 330008235 | 330001241 | 330002206 |
| 16686592 | 330034930 | ED617 | 100 | null | 1 | 2017-02-21 | NELARABINE | 330008252 | 330001244 | 330002209 |
| 16686593 | 330034933 | EE813 | 2 | X724 | 1 | 2017-08-25 | ETOPOSIDE | 330008439 | 330001284 | 330002279 |
| 16686594 | 330034933 | ED617 | 4 | x724 | 1 | 2017-08-25 | STREPTOZOCIN | 330008439 | 330001284 | 330002279 |
| 16686595 | 330034933 | EK1PP | 300 | null | 1 | 2017-09-01 | ETOPOSIDE | 330008439 | 330001284 | 330002279 |
| 16686596 | 330034933 | EW100 | 68 | X723 | 1 | 2017-09-02 | CAPECITABINE | 330008439 | 330001284 | 330002279 |
| 16686597 | 330034933 | EQ3 | 3700 | null | 2 | 2017-09-03 | TEMOZOLOMIDE | 330008439 | 330001284 | 330002279 |
| 16686598 | 330034933 | EGU02 | 100 | X722 | 1 | 2017-09-10 | CYCLOPHOSPHAMIDE | 330008439 | 330001284 | 330002279 |
| 16686599 | 330034933 | EK1PP | 1.5 | null | 5 | 2017-09-17 | STEROID | 330008439 | 330001284 | 330002279 |
| 16686600 | 330034933 | EUH | 9 | X724 | 1 | 2017-09-17 | NOT CHEMO | 330008439 | 330001284 | 330002279 |
| 16686601 | 330034934 | EE813 | 145 | x724 | 1 | 2015-02-08 | IRINOTECAN | 330008483 | 330001292 | 330002292 |
| 16686602 | 330034934 | ERA20 | null | null | 1 | 2015-02-08 | IFOSFAMIDE | 330008483 | 330001292 | 330002292 |
| 16686603 | 330034934 | EK1PP | 205 | null | 1 | 2015-02-08 | DAUNORUBICIN | 330008483 | 330001292 | 330002292 |
| 16686604 | 330034934 | EKY01 | 3 | X724 | 1 | 2015-02-08 | CETUXIMAB | 330008483 | 330001292 | 330002292 |
| 16686605 | 330034934 | EOI | 8 | null | 11 | 2015-02-09 | FLUOROURACIL | 330008483 | 330001292 | 330002292 |
| 16686606 | 330034934 | ELW | 370 | null | 1 | 2015-02-09 | STEROID | 330008483 | 330001292 | 330002292 |